A

Anjarium Biosciences

33 employees

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Drug delivery and gene therapy
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$61M

from 4 investors over 4 rounds

A

Anjarium Biosciences raised $61M on September 15, 2021

Investors: Gimv, Omega Funds, Abingworth and Surveyor Capital

FAQ